Tagged Articles

lung transplant 11 articles

Pfizer to pay $409.9 million for illegally promoting transplant drug Rapamune

Pfizer Inc., will pay $409.9 million for illegally marketing the kidney transplant drug Rapamune, according to the U.S. Justice Department. Pfizer, which acquired Wyeth Pharmaceuticals in 2009, trained its sales force to promote the drug for unapproved uses in order to boost sales with little regard for the health and safety of “a highly vulnerable patient population dependent on life-sustaining therapy,” says Antionette Henry, Food and Drug Administration (FDA) Agent in Charge. Rapamune was approved by the FDA in 1999 for kidney transplant patients to help keep the immune system from rejecting the new organ. Wyeth pushed its sales team ... Read More